This Senate resolution expresses strong support for designating July 2026 as National Sarcoma Awareness Month . It highlights sarcoma as a rare and complex cancer affecting bones and connective tissues, with over 100 identified subtypes, and notes that approximately 18,000 individuals are diagnosed and 7,600 die from it annually in the United States. The resolution emphasizes that sarcoma is often misdiagnosed and underreported, and its potential causes are not well understood, making increased public understanding crucial. The primary purpose of this designation is to raise significant awareness about sarcoma among the public and medical community. By doing so, the initiative aims to encourage more individuals to seek timely and proper diagnosis and treatment, ultimately improving patient outcomes and fostering greater research into this challenging disease.